These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1714981)

  • 21. Antiarrhythmic effects of verapamil.
    Singh BN; Nademanee K; Feld G
    Angiology; 1983 Sep; 34(9):572-90. PubMed ID: 6351674
    [No Abstract]   [Full Text] [Related]  

  • 22. [A new Soviet drug, ethacizine, in the treatment of ventricular rhythm disorders].
    Kukes VG; Smetnev AS; Ponomarenko EL; Burian EF; Starodubtsev AK
    Kardiologiia; 1983 Nov; 23(11):45-7. PubMed ID: 6197556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacodynamics and the pharmacokinetic parameters of etmozin in ventricular heart rhythm disorders].
    Kurbanov RD; Mazur NA; Piotrovskiĭ VK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):55-8. PubMed ID: 6182893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of tachycardiac arrhythmias and arterial hypertension with verapamil].
    Bender F
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1310+. PubMed ID: 4098332
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effectiveness of ethacizin in ventricular arrhythmias refractory to prior anti-arrhythmia drug therapy].
    Shugushev KhKh
    Kardiologiia; 1986 Jun; 26(6):43-7. PubMed ID: 2429007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic agents in older patients. Current state of knowledge.
    Kim CH; Daubert JP; Akiyama T
    Drugs Aging; 1994 Jun; 4(6):462-9. PubMed ID: 7521233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of heart arrhythmia with the heart sympatholytic iproveratril].
    Barousch R
    Wien Klin Wochenschr; 1967 Nov; 79(46):856-60. PubMed ID: 4174474
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia].
    Matiushin GV; Shul'man VA; Balog AI; Golovenkin SE; Bezruk AP; Ivanitskiĭ EA; Smirnova OV
    Ter Arkh; 1998; 70(6):47-50. PubMed ID: 9695227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of isoptin in angina pectoris and heart rhythm disorders].
    Doshchitsyn VL; Arshakuni RO; Zharov EI
    Kardiologiia; 1967 Aug; 7(8):32-40. PubMed ID: 4182174
    [No Abstract]   [Full Text] [Related]  

  • 30. [Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach].
    Nedostup AV; Blagova OV; Bogdanova EA; Platonova AA
    Kardiologiia; 2004; 44(1):31-8. PubMed ID: 15029146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of single intravenous administration of cordarone, ethacizine and obsidan in ventricular extrasystole in patients with chronic alcoholism during withdrawal].
    Karaush AP; Gorgaslidze AG; Smetnev AS
    Kardiologiia; 1991 Jan; 31(1):65-6. PubMed ID: 1710680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of heart rhythm disorders with beta-receptor-blocking agents].
    Bender F
    Wien Med Wochenschr; 1968 Oct; 118(40):820-1. PubMed ID: 4179696
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term use of ethacizin in outpatients with ventricular disorders of heart rhythm].
    Shugushev KhKh; Rozenshtraukh LV; Smetnev AS; Ponamarenko EL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):16-20. PubMed ID: 2432906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.
    Haedo AH; Chiale PA; Bandieri JD; Lázzari JO; Elizari MV; Rosenbaum MB
    J Am Coll Cardiol; 1986 May; 7(5):1114-20. PubMed ID: 3958370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
    Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Disamide--an antiarrhythmic agent in cardiovascular diseases].
    Kalmykova VI; Barkhatova VM
    Ter Arkh; 1968 Jan; 40(1):108-10. PubMed ID: 4194896
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
    Gülker H; Bramann HU; Brisse B; Kuhs H
    Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prospective evolution of the efficacy of antiarrhythmia therapy in paroxysmal supraventricular tachycardia in patients with the ventricular pre-excitation syndrome].
    Fomina IG; Iankin VV
    Klin Med (Mosk); 1992 Jan; 70(1):26-32. PubMed ID: 1608203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of isometric load for evaluation of the anti-arrhythmia effect of drugs].
    Gel'fgat EB; Abdullaev RF; Danilova VA; Khalilov AN
    Kardiologiia; 1988 Dec; 28(12):66-8. PubMed ID: 2468809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Four years of clinical experience with the cardio-eurhythmic action of verapamil in intravenous administration].
    Piccini A; Malfatti S
    Minerva Med; 1975 May; 66(39):1923-31. PubMed ID: 48221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.